An Innovative Treatment for Cervical Precancer (UH3)

NACompletedINTERVENTIONAL
Enrollment

1,132

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

August 15, 2024

Study Completion Date

August 15, 2024

Conditions
Cervical Intraepithelial Neoplasia
Interventions
DEVICE

CO2 standard therapy

Standard therapy using carbon dioxide for freezing of tissue

DEVICE

CryoPen

Provides a means of freezing tissue without the use of gases or liquids

DEVICE

Thermocoagulator

Thermoablation

Trial Locations (3)

Unknown

Shanxi Academy of Medical Sciences Shanxi Bethune Hospital, Taiyuan

Hospital Universitario San Ignacio, Bogotá

Instituto Salvadoreno del Seguro Social (ISSS), San Salvador

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Basic Health International

OTHER

collaborator

University of Southern California

OTHER

collaborator

Instituto Salvadoreno del Seguro Social

UNKNOWN

collaborator

Hospital Universitario San Ignacio

OTHER

collaborator

Medical College of Wisconsin

OTHER

collaborator

Shanxi Bethune Hospital

OTHER

lead

The Cleveland Clinic

OTHER